X4 Pharmaceuticals, Inc. generated $35.1M in revenue in fiscal year 2025. This represents an increase of 1250.5% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to $15.9M in revenue. The table below carries 10 fiscal years, from 2016 to 2025, and the quarters X4 Pharmaceuticals, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
XFOR Revenue by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
XFOR Revenue by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What revenue means
Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.
More X4 Pharmaceuticals, Inc. financials
Frequently Asked Questions
What was X4 Pharmaceuticals, Inc.'s revenue in fiscal year 2025?
X4 Pharmaceuticals, Inc. generated $35.1M in revenue in fiscal year 2025.
How fast is X4 Pharmaceuticals, Inc.'s revenue growing?
X4 Pharmaceuticals, Inc. (XFOR) revenue rose by 1250.5% year over year, from $2.6M to $35.1M in fiscal year 2025.
What is X4 Pharmaceuticals, Inc.'s revenue over the last twelve months?
X4 Pharmaceuticals, Inc. (XFOR) reported $15.9M in revenue over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
What was X4 Pharmaceuticals, Inc.'s revenue in the most recent quarter?
X4 Pharmaceuticals, Inc. (XFOR) reported $8.8M in revenue in Q2 2026. This represents an increase of 418.0% from the same quarter a year earlier.
What does revenue mean on a financial statement?
Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what X4 Pharmaceuticals, Inc. (XFOR) reported on that line in every period on record.